Stock Market News2 weeks United Therapeutics Stock Down Despite Q4 Earnings & Sales Beat Zacks
UTHR beats fourth-quarter estimates for both earnings and sales. Tyvaso sales fall short of estimates. Stock down in pre-market trading.
XUTHR beats fourth-quarter estimates for both earnings and sales. Tyvaso sales fall short of estimates. Stock down in pre-market trading.
X